CI:NYE-Cigna Corporation (USD)

COMMON STOCK | Healthcare Plans | NYE

Last Closing Price

USD 258.42

Change

-1.08 (-0.42)%

Market Cap

USD 90.15B

Volume

0.96M

Average Target Price

USD 260.67 (+0.87%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's U.S. Medical segment offers commercial products and services, including medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as Medicaid plans; and individual health insurance plans to on and off the public exchanges. Its International Markets segment offers health coverage, hospitalization, dental, critical illness, personal accident, term life, medical cost containment, and variable universal life products, as well as health care benefits to mobile employees of multinational organizations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-05-05 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
UNH UnitedHealth Group Incorporate..

+1.16 (+0.28%)

USD388.26B 23.39 15.20
CVS CVS Health Corporation

+1.92 (+2.37%)

USD106.80B 14.85 10.19
ANTM Anthem, Inc

-2.55 (-0.65%)

USD94.65B 20.68 N/A
HUM Humana Inc

-2.91 (-0.63%)

USD59.73B 16.45 N/A
CNC Centene Corporation

+0.73 (+1.13%)

USD37.62B 15.42 7.43
MOH Molina Healthcare, Inc

-1.63 (-0.62%)

USD15.45B 21.72 8.81
GTS Triple-S Management Corporatio..

N/A

USD0.57B 8.31 N/A

ETFs Containing CI

Symbol Name Weight Mer Price(Change) Market Cap
ESGL Invesco ESG Revenue ETF 0.00 % 0.40 %

N/A

USD0.03B
TPXE:PA Amundi Index Solutions - .. 0.00 % 0.00 %

+1.58 (+1.79%)

USD0.24B
VGVL:XETRA Vanguard Funds Public Lim.. 0.00 % 0.00 %

N/A

N/A
UET0:XETRA UBS ETF - Bloomberg Barcl.. 0.00 % 0.00 %

-0.02 (-0.09%)

USD0.53B
TTPX:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

+3.94 (+1.57%)

USD0.61B
SYB1:XETRA SPDR Bloomberg Barclays U.. 0.00 % 0.20 %

N/A

USD0.02B
MJMT:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

+1.90 (+2.29%)

USD0.41B
JP40:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

+2.50 (+1.69%)

USD0.06B
UEF0:F UBS ETF - Bloomberg Barcl.. 0.00 % 0.23 %

+0.11 (+0.59%)

USD0.37B
SYB1:F SPDR Bloomberg Barclays U.. 0.00 % 0.20 %

N/A

USD0.02B
MJMT:F Amundi Index Solutions - .. 0.00 % 0.00 %

+1.58 (+1.90%)

USD0.39B
JP40:F Amundi Index Solutions - .. 0.00 % 0.00 %

+2.44 (+1.65%)

N/A
TPXH:PA Amundi Index Solutions - .. 0.00 % 0.00 %

+3.73 (+1.48%)

USD0.61B
TPHC:PA Amundi Index Solutions - .. 0.00 % 0.00 %

+1.08 (+1.58%)

USD3.14M
FCOR Fidelity Corporate Bond E.. 0.00 % 0.36 %

+0.06 (+0.11%)

USD0.29B
UC98:LSE UBS ETF - Bloomberg Barcl.. 0.00 % 0.20 %

-2.25 (-0.17%)

USD0.29B
CGAA:CA CI Global Asset Allocatio.. 0.00 % 0.90 %

N/A

USD0.02B
SPVM Invesco S&P 500 Value wit.. 0.00 % 0.39 %

+0.18 (+0.36%)

USD0.09B
SPGP Invesco S&P 500 GARP ETF 0.00 % 0.34 %

+0.22 (+0.26%)

USD0.36B
JAGG JPMorgan U.S. Aggregate B.. 0.00 % 0.07 %

+0.04 (+0.07%)

USD0.81B
IBDT iShares iBonds Dec 2028 T.. 0.00 % 0.10 %

+0.04 (+0.14%)

USD0.23B
HONR InsightShares Patriotic E.. 0.00 % 0.65 %

N/A

USD1.34M
CHGX Change Finance U.S. Large.. 0.00 % 0.49 %

-0.09 (-0.28%)

USD0.05B
SPVU Invesco S&P 500 Enhanced .. 0.00 % 0.13 %

+0.45 (+1.05%)

USD0.12B
IHF iShares U.S. Healthcare P.. 0.00 % 0.42 %

-0.70 (-0.26%)

USD1.08B
GURU Global X Guru Index ETF 0.00 % 0.75 %

-0.44 (-0.94%)

USD0.07B
FHH:CA FT AlphaDEX U.S. Health C.. 0.00 % 0.77 %

N/A

USD0.02B
VMUS:XETRA VanEck Vectors ETFs N.V. .. 0.00 % 0.00 %

+0.41 (+0.98%)

USD9.02M

Market Performance

  Market Performance vs.
Industry/Classification (Healthcare Plans)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 24.13% 100% A+ 78% C+
Dividend Return 0.48% 80% B- 30% F
Total Return 24.61% 100% A+ 77% C+
Trailing 12 Months  
Capital Gain 40.88% 50% F 47% F
Dividend Return 0.55% 20% F 5% F
Total Return 41.43% 50% F 44% F
Trailing 5 Years  
Capital Gain 97.49% 38% F 76% C
Dividend Return 0.89% 20% F 2% F
Total Return 98.38% 38% F 73% C
Average Annual (5 Year Horizon)  
Capital Gain 11.80% 38% F 75% C
Dividend Return 0.04% 17% F 2% F
Total Return 11.84% 38% F 71% C-
Risk Return Profile  
Volatility (Standard Deviation) 20.29% 75% C 51% F
Risk Adjusted Return 58.37% 38% F 72% C-
Market Capitalization 90.15B 63% D 97% A+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Healthcare Plans)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 11.30 88% B+ 75% C
Price/Book Ratio 1.74 63% D 55% F
Price / Cash Flow Ratio 8.71 50% F 50% F
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity 17.73% 63% D 83% B
Return on Invested Capital 6.96% 38% F 65% D
Return on Assets 3.57% 25% F 68% D+
Debt to Equity Ratio 58.71% 50% F 58% F
Technical Ratios  
Short Ratio 2.62 63% D 40% F
Short Percent 1.35% 75% C 78% C+
Beta 0.91 25% F 62% D-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.